Morris Goodman

As one of Canada's leading entrepreneurs and a pioneer in the generic drug industry, Mr. Goodman has dedicated his career to "Creating the Difference" in healthcare in Canada and worldwide. He graduated from the Faculty of Pharmacy at the University of Montreal in 1953 at the young age of twenty-one.

After graduation, Mr. Goodman focused on the industry side of pharmacy and quickly obtained distribution rights from several international pharmaceutical companies to bring their products to the Canadian marketplace. He marketed and sold these products in Canada under the company name of Winley-Morris Co. Ltd.

In 1971, Mr. Goodman approached a California-based company, International Chemical & Nuclear Corporation (ICN) and became their Canadian distributor of L-Dopa. Impressed with his innovative approach, they purchased Winley-Morris and established Morris Goodman as President of ICN Canada.

In 1983, Mr. Goodman co-founded Pharmascience Inc. with his good friend and colleague, Ted Wise. As Co-Founder & Chairman of the Board of Pharmascience Inc., Morris Goodman has been at the forefront of the company's explosive growth and development, leading it to its current standing as one of the top three generic pharmaceutical companies in Canada.

Notwithstanding his business successes, Mr. Goodman is a leader in philanthropic initiatives. Included among the major charitable donations made by The Morris & Rosalind Goodman Family Foundation are The Stroke Unit at the Jewish General Hospital, the Agora at the Faculty of Pharmacy at the University of Montreal and The Goodman Cancer Research Centre at McGill University.

In May of 2011, McGill University bestowed an honorary degree upon Mr. Goodman.